---
title: "Restart Life Sciences Reports Holy Crap Foods Revenue Gains of 46% in Wholesale and 32% via Amazon Channels YoY | NMLSF Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285183666.md"
description: "Restart Life Sciences Reports Holy Crap Foods Revenue Gains of 46% in Wholesale and 32% via Amazon Channels YoY | NMLSF Stock News"
datetime: "2026-05-05T02:05:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285183666.md)
  - [en](https://longbridge.com/en/news/285183666.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285183666.md)
---

# Restart Life Sciences Reports Holy Crap Foods Revenue Gains of 46% in Wholesale and 32% via Amazon Channels YoY | NMLSF Stock News

Restart Life Sciences Reports Holy Crap Foods Revenue Gains of 46% in Wholesale and 32% via Amazon Channels YoY | NMLSF Stock News

### Related Stocks

- [ATNF.US](https://longbridge.com/en/quote/ATNF.US.md)
- [RSLS.US](https://longbridge.com/en/quote/RSLS.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [HEAL.US](https://longbridge.com/en/quote/HEAL.US.md)
- [AMZN.US](https://longbridge.com/en/quote/AMZN.US.md)

## Related News & Research

- [Dyadic International Q1 net loss narrows](https://longbridge.com/en/news/286311192.md)
- [Halozyme beats Q1 revenue estimates, sets $1 billion buyback](https://longbridge.com/en/news/285989488.md)
- [bioAffinity Technologies Reports Record Monthly CyPath® Lung Unit Sales and Significant Year-Over-Year Growth in April 2026 | BIAF Stock News](https://longbridge.com/en/news/286107351.md)
- [Wave Life Sciences posts positive RestorAATion-2 data; WVE-006 restores M-AAT, cuts Z-AAT, supports monthly dosing](https://longbridge.com/en/news/286818220.md)
- [Precigen Q1 revenue beats estimates on PAPZIMEOS launch](https://longbridge.com/en/news/286311056.md)